BeStock  
Markets › Compare › COAG vs ESQ

COAG vs ESQ

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
COAG · Hemab Therapeutics Holdings$30.59 ▼ 1.67%
ESQ · Esquire Financial$118.02 ▼ 1.58%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6893118142167May 1, '26Jul 20, '26Oct 5, '26
  • COAG -10.0%
  • ESQ +10.7%

Head to head

MetricCOAGESQ
Price$30.59$118.02
Change today▼ 1.67%▼ 1.58%
Market cap$1.43B$1.43B
Return, 3 months-2.9%-1.9%
Return, year to date–+16.2%
Return, 1 year–+13.6%
P/E (TTM)-17.219.5
P/B3.14.6
P/E percentile vs own 5y––
Dividend yield–0.64%
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)2246
30-day volatility59.2%26.3%
Max drawdown, 1 year-44.3%-15.9%
Trend readStrong downtrendLeaning bearish
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • COAG is the largest of the group by market value.
  • COAG carries the lowest trailing P/E.
  • ESQ has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top